CCB Portal Please support MJHS Institute
Facebook Twitter YouTube LinkedIn

Interprofessional Webinar Series:
Thrombosis and Bleeding:  Managing Common Problems in Advanced Illness

This webinar is presented in collaboration with the
National Hospice and Palliative Care Organization.

Funding Disclosure:  No commercial funding has been accepted for the activity.

Date and Time:  February 4, 2016, 12:30 PM – 1:30 PM ET (Live)

Location:   Online at http://www.mjhspalliativeinstitute.org/e-learning/

Speaker Name and Title:
Mona S. Patel, DO
Associate Program Director of Hospice and Palliative Medicine Fellowship
MJHS Hospice & Palliative Care
New York, NY

Purpose:  This webinar will address the clinical challenges associated with the treatment of thrombosis in patients with advanced illness and review the risk of bleeding in the hospice and palliative care patient requiring anticoagulant therapy.

Objectives:  Participants will be able to:

  1. Discuss the current guidelines regarding management strategies for thrombosis and the clinical challenges in applying these guidelines to patients with advanced illness.
  2. Identify and review the risks, benefits and burdens of the current armamentarium of anticoagulants, including the addition of recent newer therapies, as it relates to the hospice and palliative care patient.
  3. Recognize the importance of ongoing assessment of thrombosis and bleeding risk as goals of care evolve throughout the patient’s disease trajectory.

Why Do I Need to Know This?  Palliative care and hospice providers commonly care for patients diagnosed with thromboembolic disease and questions frequently arise regarding anticoagulation management. Given the limited available evidence that exists regarding this controversial topic, this webinar will assist the palliative care and hospice clinician in weighing the risks, benefits and burdens of treatment options.

Target Audience:  palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advanced practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students

Criteria for Successful Completion:

  1. Attendance at entire session (mandatory for nurses)
  2. Submission of completed evaluation form (mandatory to receive CE/CME credit for MDs and nurses)

Continuing Education Credits:  1.0

Continuing Education Accreditation:

Physicians:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Hospice and Palliative Care Organization (NHPCO) and MJHS. NHPCO is accredited by the ACCME to provide continuing medical education for physicians.

NHPCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:  NHPCO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

NHPCO designates this live activity for a maximum of 1.0 contact hour. Nurses should claim only the contact hours commensurate with the extent of their participation in the activity. Accredited status by ANCC refers only to continuing nursing education and does not imply endorsement of any commercial product discussed in conjunction with this activity.

Fees:
Individual:  $25 (includes CME/CE certificate)
Group:  $65 + $5 per CME/CE certificate

Registration fees for webinars are not refundable.

System Requirements for Computers and Mobile Devices:
http://support.citrixonline.com/en_US/Webinar/help_files/G2W010003

Disclosures

Mona S. Patel, DO, Faculty, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.

Russell K. Portenoy, MD, Planner, has indicated a relationship with Pfizer Inc. for research grant support.

No other Planning Committee Member has any disclosures.

Planning Committee Members
Barbara Bouton, MA, FT
Colleen Fleming-Damon, PhDc, APRN-BC, ACHPN-BC, C.T.
Steven R. Gardner, MPA, PAHM
Myra Glajchen, DSW
Jennifer Kennedy, RN, MA, BSN, CHC
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Judith A. Skretny